[1]
2024. Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor. Iranian Journal of Kidney Diseases. 18, 2 (Jun. 2024), 108–117. DOI:https://doi.org/10.52547/es880614.